chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a unspecified number of patients. Reporter stated she had no patient data available. On an unknown date the patients were vaccinated with M-M-R II 0.5 ml, (dose unspecified in series) subcutaneously. Lot number or expiry data were not available (no dates were expired). On an unknown dates the patients received doses of M-M-R II which were exposed to 9C degree for 360 hours. No adverse effect reported. This is one of several reports received from the same reporter. Additional infuriation has been requested.
Information has been received from a pharmacist concerning that her 22 year old female pharmacy technician who on 19-JUN-2008, was vaccinated with her first dose of GARDASIL (Lot# 0151X) 0.5ml, IM. The patient experienced extremely light periods ever since she was vaccinated. The patient's extremely light periods persisted. The pharmacist does not think her technician had contacted her physician regarding this. A pregnancy test was negative, PAP was normal. Additional information has been requested.
4/21/12 Hives-generalized and mild developed, then on 4/27/12 hives worsened. On 4/30/12 hives continued, edema of face & lips developed and vomiting occurred. Pt was seen in ER on 4/30/12 and was treated with Benedryl and Zantac. 5/1/12 Pt reports improvement in symptoms.
Vasovagal syncope with loss of bladder control. PCP notified. Father instructed to follow up with PCP. Pt. recovered in office, A plus o x3, sent home with parent.
The symptoms are dizzy, headaches, and chills and it started around 4:00 a.m. 3/12/2021. I still feel dizziness occasionally every hour.
PRESENT OF FACIAL PARALYSIS ON  THE RIGHT SIDE OF THE FACE AFTER THE SECOND DOSE OF THE VACCINE.  LOSS OF STRENGTH RIGHT SIDE OF THE FACE FROM EYE TO THE MOUTH. I CAN NOT MOVE THE LIPS AND CLOSED THE RIGHT EYE.
flu; Initial information received on 30-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who had flu after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (form, strength, dose, frequency, site, route: unknown, with an unknown batch number and expiry date: unknown) for prophylactic vaccination (Immunisation)  On an unknown date the patient had flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Reportedly "Had a flu shot three weeks ago. Came down with a severe case of the flu"  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome was Unknown for the event
swelling of the arm; This spontaneous report was received from a physician and refers to a 67-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) administered intramuscularly (dose, anatomical location, lot # and expiration date were not provided) as pneumococcal vaccine. On an unknown date (reported as approximately 48 hours after vaccination), she experienced swelling of the arm. It was unknown whether the patient received any treatment for the event. Outcome of the event was reported as recovered.  Causality assessment was not provided
Dizziness - patient turned pale, C/O dizziness, low BP right after the shot within 1-2 minutes.
COVID (+) WITH SYMPTOMS RUNNY NOSE, COUGH AND HEADACHES Narrative:
fatigue, fever,  and body aches.  Tested positive for covid19 on 5/7/2021
Pain under her arm; HCP was administered PNEUMOVAX 23 and experienced puffiness/swelling at the injection site; HCP was administered PNEUMOVAX 23 and experienced redness; the HCP received the PNEUMOVAX23 because she is asthmatic; This spontaneous report has been received from other health professional regarding to herself as female patient of unknown age.The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.   On an unknown date in 2014, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, as treatment for asthma (product use in unapproved indication) (strength, dosage, route of administration, anatomical site of injection, vaccination scheme frequency, lot number and expiration date were not reported). On an unspecified date, the patient experienced puffiness, swelling (injection site swelling), and redness (injection site erythema), at the injection site as well as pain under her arm (pain in extremity). At the time of reporting, the outcome of injection site swelling, injection site erythema, and pain in extremity was not provided   The causality assessment between the aforementioned events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) was not reported.
This is a spontaneous case, initially received from other non-health professional (consumer) on 21-Dec-2017, concerning a 38-year-old, adult, male patient. The patient's current condition included: egg allergy and hypertension (since an unspecified dates). The patient's concomitant medication included: unspecified medication which was used to control hypertension (reported as hypertension was well controlled with medication). On 19-Dec-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch no: 195129, expiry date: 30-Apr-2018). On an unspecified date in Dec-2017, after 12 hours of vaccination, the patient experienced projectile vomiting, tingling in hands and feet. In addition, he was very lethargic. However, the patient did not receive any treatment for the events. The patient had recovered from the events projectile vomiting, tingling feet/hands and not yet recovered from the event lethargic. The reporter assessed all the events as non-serious.
Female patient 72 y/o reports that for three days after vaccination she experiences itching and redness in the arm where she was immunized, three days after vaccination she reports that the itching radiates to the rest of the arm. On Thursday after being immunized, she reported itching in the head and ears and inflammation and itching in the throat. On Friday of the same week the patient began to show reddened blisters on her legs and arms which caused itching. On Friday afternoon the itching in her feet began which leads her to visit the hospital, where she is prescribed Benadryl and Medrol Pack. On Tuesday, October 4, 2022, he reported not being able to walk due to the pain in the blisters, and that the rest of the symptoms continue, as well as hoarseness and today he shows redness on his face.
The patient was vaccinated by the RN.  At approximately 14:10, the patient was dismissed without any complaints.  As the mother was driving away she called out "help".  The RN approached the vehicle and found the patient awake and alert.  His color was pale.  Skin was warm and dry.  The patient's BP was 92/60.  The patient's mother stated that she witnessed the patient briefly "passed out".  EMS was called.  The patent was given water and was able to answer questions.   The patient was assessed by EMS.  The patient declined transport to the hospital.  When the patient left this clinic, he was alert and talking.  Follow up with Mom phone call.  She stated that she contacted the patient's PCP.  Further questioning with the patient revealed that the patient did not have any fluids since the day before.  No further medical attention was recommended from the patient's PCP.
16MAY98 pt had rash on face & trunk;temp 104.5 16MAY98;104 17MAY98;no 18MAY98;rash still present @ the time of their report 18MAY98;
I woke up from sleep with severe chest pain at approx. 0400. It was sharp and radiated up to the left side of my neck. The pain was worse with breathing whether I was sitting up or lying down. My heart rate was 150 initially, but came down to 110's after a few minutes of waking up.  My heart rate did not decrease with rest and the chest pain was not going away, so I drove to the emergency room to be checked. Before I left the house I used my albuterol inhaler once to see if it would make the chest pain and tightness any better.  I received an EKG, mylanta mixed with lidocaine, IV pepcid and IV torodol to help relive the pain. The pain eased some (was a 8/10 when I awoke to a 2/10 after treatment). My blood was drawn, a chest x-ray was taken and the provider informed me all of my lab results, chest x-ray, and physical examination was normal. My EKG showed tachycardia and my heartrate did not drop below 100 beats per minute throughout the whole ER visit.  My BP at the highest was 151/94.  I have never had a problem with a fast heartrate or high blood pressure in the past.  I was discharged with a diagnosis of pleurisy caused by a cough I have been having.  I spent the rest of the day with chest pain and left arm pain from the site of the vaccination.
Client reports that she received the vaccine at approx. 11 AM on 04/10/2021. At approx. 2 PM that day, she states that she felt very irritable. Throughout the week she states she felt very "weepy" and emotional along with irritability. Today  the client states she has become very shaky. She states it's "not uncontrollable but I was having trouble holding a pen and using a keyboard, and I had to leave work." Recommended that she call her PCP and report these things to them as well. She voiced understanding.
First my lymph nodes and arm did swell which is normal however 6 hrs later my arm was 3xs it?s normal size and I had hives all over my body.
Chills, headache, temperature of 101.8°, aching, tired, no appetite
Information has been received from a nurse practitioner concerning a 24 year old female with sports induced asthma and sulfonamide allergy who on 07-JUN-2010 was vaccinated with the first dose of GARDASIL  (Lot# 663599/1178Y), 0.5 ml, IM in her left deltoid. Concomitant therapy included oral contraceptives (unspecified). On 07-JUN-2010 the patient experienced numbness in one finger and leg. She had been examined by a neurologist and was scheduled to have a MRI (magnetic resonance imaging) and computed axial tomography (CAT) scan of spine. The patient had comprehensive metabolic panel, thyroid-stimulating hormone (TSH) level, B12 level, Lyme, complete blood count performed (results not reported). At the time of the report, the patient had not recovered from numbness in one finger and leg. Additional information has been requested.
A report has been received from a physician via medical representative concerning an adult female patient, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started during 2008. The patient experienced severe inflammation of upper soft palate which started during 2008. The patient recovered from the event of inflammation of upper soft palate on an unspecified date. The report was considered to be non-serious by the reporter.
She is talking a lot, she is out of breath; Anxiety; Nervousness; She felt in her arm/Went into fingertips/ Tingling and numbness feeling; She felt in her arm/Went into fingertips/ Tingling and numbness feeling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling), HYPOAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling), DYSPNOEA (She is talking a lot, she is out of breath), ANXIETY (Anxiety) and NERVOUSNESS (Nervousness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No medical history was reported.     On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PARAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling) and HYPOAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling). On an unknown date, the patient experienced DYSPNOEA (She is talking a lot, she is out of breath), ANXIETY (Anxiety) and NERVOUSNESS (Nervousness). At the time of the report, PARAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling), HYPOAESTHESIA (She felt in her arm/Went into fingertips/ Tingling and numbness feeling), DYSPNOEA (She is talking a lot, she is out of breath), ANXIETY (Anxiety) and NERVOUSNESS (Nervousness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medication includes asthma and has inhaler. No Treatment information was  provided.
Pt reported hyperekplexia with dose #2 of shingrix. Pt went to the ER where they monitored her. Pt has a large PMH that includes hyperekplexia.
Could not bend the knee; barely walk; lower back pain; lower back swelling; 1st dose 27Sep2021, 2nd not yet; Circular Shingles Rash on stomach area; Knee Swelling; Pain behind the knee; This case was reported by a nurse via sales rep and described the occurrence of shingles in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 27th September 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient did not receive the 2nd dose of Shingrix. On 28th September 2021, 1 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced swelling of knees and knee pain. On 14th October 2021, the patient experienced shingles. On an unknown date, the patient experienced stiff joint, walking difficulty, low back pain, local swelling and incomplete course of vaccination. The patient was treated with prednisone and valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles, swelling of knees, knee pain, stiff joint, walking difficulty, low back pain, local swelling and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles, swelling of knees, knee pain, stiff joint, walking difficulty, low back pain and local swelling to be related to Shingrix.     Additional Information: GSK Receipt Date: 05-OCT-2022 Reporter's Comments: At the time of reporting, the patient age was over 50 years old. The patient received first dose of Shingrix and next morning, the patient had knee swelling and pain behind the knee. The patient reported that she could not bend the knee or barely walk also reported lower back swelling and lower back pain. The patient reported that she went to an emergency room walking clinic on 14th October 2021. On 14th October 2021 the patient was treated with Valtrex and Prednisone. The patient reported that she developed a circular shingles rash on the stomach area. The patient had not gotten the second dose of Shingrix. Emergency room visit required. The reporter reported that not all information was available, and lot and expiration date were not provided. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Initial report received from a health care professional via another manufacturer on 08 June 2011. A patient (age and sex not reported) received on an unspecified date an injection (route and site not reported) of SMALLPOX VACCINE, manufacturer and lot number not reported. On an unspecified date described as "years ago", a patient subsequently lapsed into a coma. No further information was available. The outcome was not reported. Documents held by sender: None.
accute hearing loss; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Jun-2021 and was forwarded to Moderna on 02-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS (accute hearing loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEAFNESS (accute hearing loss) (seriousness criterion medically significant). At the time of the report, DEAFNESS (accute hearing loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided.  Company comments: Very limited information regarding this event has been provided at this time.  Further information can't be requested.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information can't be requested.
Red band around arm just below injection site. Hives and rash all over body within 24 to 30 hours which lasted 6 days. Took antihistamine and used cortisone cream to try to relieve itching.
Patient's mom mistakenly provided incorrect date of birth (12yo instead of 11yo) when patient received the first dose. When spoke with patient's doctor, she said patient is not experiencing any side effects and not to give 2nd dose until patient turns 12 yo
Severe headaches for three days. Inability to concentrate, feeling off for 3 days. Nonspecific malaise.
Reaction from Flu shot. Dizziness, Weakness and numbing of arms and legs. Shot received on October 16, 2019. Symptoms onset started October 23, 2019. Required physician treatment. States reaction settled in lower back then dissipates, numbness in bilateral legs, foot cold, legs felt heavy, increased heart rate, night sweats times 3 nights.  After high dose prednisone, strength back and some dizziness
No adverse event, It was an administration error, MMR was given on 10/10/22 and after it was given, expiration date was noted as 10/08/2022, so it had expired 2 days prior to being given.  Father was contacted and child is fine, no adverse event occurred. No clinic visit was required but patient will receive MMR again at next visit age 15 months, father is agreeable, as a result of this error, extra training was conducted at todays staff meeting for preventing future administration errors
This spontaneous report as received from a medical assistant refers to a 13 year old female patient. On 03-AUG-2011, the patient was vaccinated with a first dose of GARDASIL (lot number was reported as 0306AA, expiry date: 10-MAY-2013, dose and route were not reported) and on 24-JUN-2013, the patient was vaccinated with a second dose of GARDASIL (lot # H021861, expiry date: 09-OCT-2015, dose and route were not reported). No adverse effect reported. Additional information has been requested.
patient felt faint, dizzy, like passing out but did not, looked pale, fine after water, food, and observation
pain in arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product HUMIRA injection for Plaque psoriasis.    No Medical History information was reported.   In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started HUMIRA (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm). At the time of the report, PAIN IN EXTREMITY (arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (arm) to be probably related.    No concomitant medications were reported. Moderna COVID-19 Vaccine was administered on an unknown date in 2021.  No treatment drugs were reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Additional document received on 24 May 2021 had no new information. On 20-Jul-2021: Follow up received on 20 Jul 2021 contains no new information.
Fever, chills, nausea, stomach pain, headache, ice pick headaches, gray spot in right eye vision, joint pain, muscle aches
Our patient received a Pfizer monovalent COVID vaccine on 8/31 as their booster dose. Patient had no adverse reaction. On August 31, 2022, the Administration amended emergency use authorizations of the Pfizer and Moderna COVID-19 vaccines to authorize updated, bivalent formulations of the vaccines for use as a single booster dose.   The Administration has removed the authorization to use the original monovalent Moderna and Pfizer COVID-19 vaccines as boosters for adults and adolescents. This means, individuals 12 years and older can no longer be given booster doses with the original monovalent COVID-19 vaccines.
Patient complained that vaccine hurt when injected. She returned two days later saying her arm was extremely sore on the under side of her arm to the point she couldn't even raise it. She also had a large bruise around the injection site and it was in a strange pattern that was only bruised around the bandage (left the bandage shape out of the bruise). I called her back today and she has improved.
Per mom pt received 1 vaccine on 9-14-15 on 9-15-15 pt broke out in rash from head to toe. Went to urgent care given BENADRYL and steroids per mom.
pale & limp 2-3 hrs p/crying 3 hrs p/immun lips purple;
About a week after the vaccine I broke out in a rash and welts and was very itchy.   This lasted about 8 or 9 days and went away on its own.
Approximately 10 minutes after receiving the vaccine patient started to complain of sensation of her throat closing and shortness of breath. Patient flushed on her upper chest. EMS called.   Upon exam she was slightly tachycardic with heart rate of 108. No visible oral, facial or neck swelling noted. Lungs clear bilaterally and moving air well. Patient stated that she started to have bilateral ear itching after another few minutes. No acute distress noted. Patient speaking clearly and in full sentences. Skin warm and dry. Patient stated that her flushing and throat sensation started to improve prior to EMS arrival.   Patient evaluated and cleared by EMS. Patient noted no acute concerns prior to leaving and verbalized understanding to call 911 or go to ER if symptoms change or worsen.  Follow up call placed to patient 12/31 @ 1833. She states that she is feeling better and currently has no symptoms. She notes that she took 1 Benadryl when she got home with improvement of symptoms and another 1/2 of a Benadryl 30 min prior to call due to continued ear itching. She denies shortness of breath at this time. She denies any neck, facial or oral itching. Speech was clear and she was speaking in complete sentences. She verbalized understanding to call 911 or go to ER if symptoms change or worsen.
About a week after her second shot in left arm, patient developed burning/numbness/tingling in right arm then in left arm. Patient reports that it is very painful. Patient states can't tolerate any pain relievers and does not have a primary care provider to see, even though the pharmacist suggested it.